张薇,王志强,周志明,杨士伟,贾德安,韩红亚,周玉杰

• 1:首都医科大学附属北京安贞医院心内12病区
• 2:北京市心肺血管疾病研究所冠心病精准治疗北京市重点实验室首都医科大学冠心病临床诊疗与研究中心

摘要(Abstract)：

目的探讨可能对冠状动脉左前降支近段临界病变血流储备分数(FFR)产生影响的因素。方法纳入2017年9月至2020年1月首都医科大学附属北京安贞医院167例冠状动脉左前降支近段临界病变的患者,行左前降支FFR检查,根据FFR值分为FFR≥0.75组(105例)及FFR<0.75组(62例),比较两组患者相关临床指标的差异,探讨FFR值与病变狭窄程度之间的关系。进行logistic多因素回归分析与FFR值相关的因素。结果两组患者性别、年龄、吸烟史、合并高血压病、合并糖尿病、体重指数、左心室射血分数、最小管腔直径、直径狭窄率、空腹血糖、总胆固醇、高密度脂蛋白胆固醇以及糖化血红蛋白水平等比较,差异均无统计学意义(均P>0.05);FFR<0.75组病变长度[(20.17±7.42)mm比(16.98±6.01)mm,P=0.045]及分支血管积分[(3.36±1.38)分比(2.71±1.04)分,P=0.023]显著大于FFR≥0.75组,差异有统计学意义。Pearson相关分析显示,FFR值与直径狭窄率无相关关系(r=0.371,P=0.067)。logistic多因素回归分析显示,病变长度(OR 2.197,95%CI 1.608～3.372,P=0.017)、分支血管积分(OR 2.101,95%CI 1.079～3.035,P=0.020)与FFR<0.75相关。结论左前降支近段临界病变冠状动脉狭窄的病变长度及病变以远的分支血管积分可能对FFR值产生影响。

关键词(KeyWords)： 冠状动脉;临界病变;血流储备分数

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划“精准医学研究”重点专项（2017YFC0908800）;; 北京市医院管理局“登峰”计划专项（DFL20150601）;北京市医院管理局“使命”计划专项（SML20180601）;; 北京市卫生健康委员会科技创新中心建设项目（PXM2019_026272_000006、PXM2019_026272_000005）

作者(Author): 张薇,王志强,周志明,杨士伟,贾德安,韩红亚,周玉杰

参考文献(References)：

• [1] Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography:executive summary and recommendations.A report of the American College of Cardiology/American Heart Association task force on practice guidelines(committee on coronary angiography)developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation, 1999,99(17):2345-2357.
• [2] Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J, 2019, 40(2):87-165.
• [3] Levine GN, Bates ER, Blankenship JC,et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention:a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation,2011,124(23):e574-e651.
• [4]中华医学会心血管病学分会介入心脏病学组，中国医师协会心血管内科医师分会血栓防治专业委员会，中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南（2016）.中华心血管病杂志，2016,44(5):382-400.
• [5] Toth G, Hamilos M, Pyxaras S, et al. Evolving concepts of angiogram:fractional flow reserve discordances in 4000 coronary stenoses. Eur Heart J, 2014, 35(40):2831-2838.
• [6] Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for grading of coronary artery disease, Council on Cardiovascular Surgery, American Heart Association. Circulation,1975, 51(4 Suppl):5-40.
• [7] Shibutani H, Fujii K, Matsumura K, et al. Diff erential influence of lesion length on fractional flow reserve in intermediate coronary lesions between each coronary artery. Catheter Cardiovasc Interv,2020, 95(6):168-174.
• [8]《中国冠状动脉血流储备分数测定技术临床路径专家共识》专家组.中国冠状动脉血流储备分数测定技术临床路径专家共识.中国介入心脏病学杂志，2019,27(3):121-133.
• [9] Adjedj J, Stoyanov N, Muller O. Comparison of coronary angiography and intracoronary imaging with fractional flow reserve for coronary artery disease evaluation:An anatomical-functional mismatch.Anatol J Cardiol, 2018, 20(3):182-189.
• [10] De Bruyne B, Fearon WF, Pijls NHJ, et al. Fractional flow reserveguided PCI for stable coronary artery disease. N Engl J Med, 2014,371(13):1208-1217.
• [11] Zimmermann FM, Ferrara A, Johnson NP, et al. Deferral vs.performance of percutaneous coronary intervention of functionally non-signifi cant coronary stenosis:15-year follow-up of the DEFER trial. Eur Heart J, 2015, 36(45):3182-3188.
• [12] Wong DTL. The prognostic value of residual coronary stenoses after functionally complete revascularisation. Cardiovasc Diagn Ther,2017, 7(Suppl 2):S63-S65.
• [13] Clarke JD, Duarte Lau F, Zarich SW. Determining the signifi cance of coronary plaque lesions:physiological stenosis severity and plaque characteristics. J Clin Med, 2020, 9(3):665-667.
• [14] Whayne Jr TF, Shelton JE, Deutsch CR, et al. Imaging characteristics and significance of coronary artery mismatch lesions. Angiology,2019, 70(8):685-687.
• [15] Imai S, Kondo T, Stone GW, et al. Abnormal fractional flow reserve in nonobstructive coronary artery disease. Circ Cardiovasc Interv, 2019, 12(2):e006961.
• [16] Ciccarelli G, Barbato E, Toth GG, et al. Angiography versus hemodynamics to predict the natural history of coronary stenoses:fractional flow reserve versus angiography in multivessel evaluation2 substudy. Circulation, 2018, 137(14):1475-1485.
• [17] Poh KK, Ambegaonkar B, Baxter CA, et al. Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region:results from the Dyslipidemia International StudyⅡ. Eur J Prev Cardiol, 2018, 25(18):1950-1963.
• [18] Pijls NH, De Bruyne B, Peels K. et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med, 1996, 334(26):1703-1708.
• [19] Kang DY, Ahn JM, Lee CH, et al. Deferred vs. performed revascula riza tion f or corona r y stenosis wit h grey-zone f ractional f low reserve values:data from the IRIS-FFR registry.Eur Heart J, 2018, 39(18):1610-1619.
• [20] Cerrato E, Mejía-Rentería H, Dehbi H-M, et al. Revascularization deferral of nonculprit stenoses on the basis of fractional flow reserve:1-year outcomes of 8,579 patients. JACC Cardiovasc Interv, 2020, 13(16):1894-1903.